Interesting sets of expectations. I thought everything would be as expected? They are waiting for tier 3 and the new DC is not even build. Where is that revenue jump possibly coming from?
If the DC is up and tier 3 accredited and they don’t start moving sales then it’s a problem of poor execution or simply lack of demand. Until then, I don’t see where the drama is at.
Looking at the price volume movement, it seems the market agrees that the results are to be as expected.
- Forums
- ASX - By Stock
- AI1
- Ann: June 2021 Quarterly Report and Appendix 4C
Ann: June 2021 Quarterly Report and Appendix 4C, page-13
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AI1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.71M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AI1 (ASX) Chart |
Day chart unavailable
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online